Assessing Different FVIII Doses and Frequencies in Immune Tolerance Induction (ITI) with ADVATE Among Hemophilia a Boys with Inhibitor (INITIATE Study)
Clinical trial NCT06864975 · RECRUITING
Trial details
- NCT number
- NCT06864975
- Sponsor
- Runhui WU
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-01
- Primary completion
- 2028-03-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.